77 related articles for article (PubMed ID: 20739132)
1. Longitudinal study of bone mineral density in children after a diagnosis of Crohn's disease.
Samson F; Cagnard B; Leray E; Guggenbuhl P; Bridoux-Henno L; Dabadie A
Gastroenterol Clin Biol; 2010 Oct; 34(10):554-61. PubMed ID: 20739132
[TBL] [Abstract][Full Text] [Related]
2. [Low bone mineral density in children with Crohn's disease].
Bourges O; Dorgeret S; Alberti C; Hugot JP; Sebag G; Cézard JP
Arch Pediatr; 2004 Jul; 11(7):800-6. PubMed ID: 15234375
[TBL] [Abstract][Full Text] [Related]
3. [Bone mineral density in inflammatory bowel diseases in children].
Szumera M; Landowski P; Kamińska B; Góra-Gebka M; Popadiuk S; Renke J
Med Wieku Rozwoj; 2006; 10(2):445-51. PubMed ID: 16825715
[TBL] [Abstract][Full Text] [Related]
4. [Bone metabolism in 53 children and adolescents with chronic inflammatory bowel disease].
Scheer K; Kratzsch J; Deutscher J; Gelbrich G; Borte G; Kiess W
Klin Padiatr; 2004; 216(2):62-6. PubMed ID: 15106075
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha haplotype is strongly associated with bone mineral density in patients with Crohn's disease.
Lee N; Fowler E; Mason S; Lincoln D; Taaffe DR; Radford-Smith G
J Gastroenterol Hepatol; 2007 Jun; 22(6):913-9. PubMed ID: 17565648
[TBL] [Abstract][Full Text] [Related]
6. [Bone loss owing to inflammatory bowel disease: prospective study, 50 cases].
Ben Hamida KS; Serghini M; Ksontini I; Kedadi H; Ben Yaghléne L; Bougassas W; Dougui MH
Tunis Med; 2009 Feb; 87(2):144-8. PubMed ID: 19522449
[TBL] [Abstract][Full Text] [Related]
7. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation.
Abeş M; Sarihan H; Madenci E
J Pediatr Surg; 2003 Feb; 38(2):230-2. PubMed ID: 12596110
[TBL] [Abstract][Full Text] [Related]
9. Gender, age, and body weight are the major predictive factors for bone mineral density in Crohn's disease: a case-control cross-sectional study of 113 patients.
Andreassen H; Hylander E; Rix M
Am J Gastroenterol; 1999 Mar; 94(3):824-8. PubMed ID: 10086673
[TBL] [Abstract][Full Text] [Related]
10. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation.
Vogelsang H; Ferenci P; Resch H; Kiss A; Gangl A
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):609-14. PubMed ID: 8590154
[TBL] [Abstract][Full Text] [Related]
11. A two-year longitudinal study of persistent lean tissue deficits in children with Crohn's disease.
Sylvester FA; Leopold S; Lincoln M; Hyams JS; Griffiths AM; Lerer T
Clin Gastroenterol Hepatol; 2009 Apr; 7(4):452-5. PubMed ID: 19249399
[TBL] [Abstract][Full Text] [Related]
12. Treatments for Crohn's disease that minimise steroid doses are associated with a reduced risk of osteoporosis.
Dear KL; Compston JE; Hunter JO
Clin Nutr; 2001 Dec; 20(6):541-6. PubMed ID: 11884003
[TBL] [Abstract][Full Text] [Related]
13. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.
Dresner-Pollak R; Karmeli F; Eliakim R; Ackerman Z; Rachmilewitz D
Am J Gastroenterol; 2000 Mar; 95(3):699-704. PubMed ID: 10710060
[TBL] [Abstract][Full Text] [Related]
14. Hyperhomocysteinaemia is associated with osteoporosis in patients with Crohn's disease.
Roblin X; Phelip JM; Genevois M; Ducros V; Bonaz B
Aliment Pharmacol Ther; 2007 Apr; 25(7):797-804. PubMed ID: 17373918
[TBL] [Abstract][Full Text] [Related]
15. A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software.
Firouzi F; Rashidi M; Hashemi S; Kangavari M; Bahari A; Daryani NE; Emam MM; Naderi N; Shalmani HM; Farnood A; Zali M
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1075-81. PubMed ID: 17998832
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease?
de Jong DJ; Corstens FH; Mannaerts L; van Rossum LG; Naber AH
Am J Gastroenterol; 2002 Aug; 97(8):2011-5. PubMed ID: 12190169
[TBL] [Abstract][Full Text] [Related]
17. [Osteodensitometry in children and adolescents with inflammatory bowel disease].
Kluge G; Borte M; Richter T; Kahn T; Borte G
Rofo; 2007 Jan; 179(1):58-64. PubMed ID: 17203445
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density in children with celiac disease. Effect of a Gluten-free diet.
Tau C; Mautalen C; De Rosa S; Roca A; Valenzuela X
Eur J Clin Nutr; 2006 Mar; 60(3):358-63. PubMed ID: 16319837
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of controlled-release budesonide in preserving bone mineral density in patients with Crohn's disease.
Abreu MT
Nat Clin Pract Gastroenterol Hepatol; 2005 May; 2(5):210-1. PubMed ID: 16265201
[No Abstract] [Full Text] [Related]
20. Effect of a gluten-free diet on bone mineral density in children with celiac disease.
Heyman R; Guggenbuhl P; Corbel A; Bridoux-Henno L; Tourtelier Y; Balençon-Morival M; de Kerdanet M; Dabadie A
Gastroenterol Clin Biol; 2009 Feb; 33(2):109-14. PubMed ID: 19201117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
